We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
426
Applied Materials
AMAT
$355B
| $20.3M | 0.04% |
110,747
-168,985
| -60% | -$26.8M |
2013 Q2
48 quarters
|
|
427
Vertex
VERX
$2.06B
| $20.3M | 0.04% |
573,365
-613
| -0.1% | -$23.3K |
2024 Q2
4 quarters
|
|
428
DELISTED
REV Group
REVG
| $20.2M | 0.04% |
425,003
-44,254
| -9% | -$1.65M |
2023 Q2
8 quarters
|
|
429
Simon Property Group
SPG
$64.3B
| $20.1M | 0.04% |
124,912
+50,932
| +69% | +$8.05M |
2013 Q2
48 quarters
|
|
430
National Vision
EYE
$1.31B
| $19.9M | 0.04% |
863,683
+2,156
| +0.3% | +$36.8K |
2023 Q4
6 quarters
|
|
431
Emerson Electric
EMR
$89B
| $19.7M | 0.04% |
147,622
-25,499
| -15% | -$2.93M |
2013 Q2
48 quarters
|
|
432
Intuit
INTU
$81.7B
| $19.6M | 0.04% |
24,874
-14,799
| -37% | -$10M |
2013 Q2
48 quarters
|
|
433
Exelon
EXC
$43.7B
| $19.4M | 0.04% |
447,100
+307,745
| +221% | +$13.7M |
2013 Q2
48 quarters
|
|
434
DELISTED
Aris Water Solutions
ARIS
| $19.3M | 0.04% |
816,200
+78,085
| +11% | +$1.93M |
2021 Q4
14 quarters
|
|
435
PVH
PVH
$3.76B
| $19.3M | 0.04% |
281,149
+23,203
| +9% | +$1.68M |
2013 Q2
48 quarters
|
|
436
IQVIA
IQV
$43.1B
| $19.3M | 0.04% |
122,260
+4,701
| +4% | +$708K |
2017 Q3
31 quarters
|
|
437
CNO Financial Group
CNO
$4.96B
| $19.2M | 0.04% |
498,911
-816
| -0.2% | -$31.1K |
2013 Q2
48 quarters
|
|
438
Halozyme
HALO
$13.4B
| $19.1M | 0.04% |
368,066
+8,529
| +2% | +$485K |
2015 Q2
40 quarters
|
|
439
Bankunited
BKU
$2.93B
| $19.1M | 0.04% |
537,669
+4,262
| +0.8% | +$143K |
2023 Q4
6 quarters
|
|
440
Charles River Laboratories
CRL
$14.5B
| $19.1M | 0.04% |
126,066
+125,841
| +55,929% | +$16.8M |
2013 Q2
48 quarters
|
|
441
Nextpower Inc. Common Stock
NXT
$12.8B
| $18.9M | 0.04% |
347,935
-19,845
| -5% | -$995K |
2023 Q3
7 quarters
|
|
442
Skywest
SKYW
$3.58B
| $18.6M | 0.04% |
180,677
+686
| +0.4% | +$65.2K |
2015 Q4
38 quarters
|
|
443
Archrock
AROC
$5.21B
| $18.6M | 0.04% |
747,713
+80,177
| +12% | +$1.96M |
2023 Q3
7 quarters
|
|
444
DELISTED
The AZEK Co
AZEK
| $18.5M | 0.03% |
340,000
-7
| -0% | -$351 |
2022 Q3
11 quarters
|
|
445
Ingersoll Rand
IR
$30.3B
| $18.4M | 0.03% |
220,687
-10,654
| -5% | -$840K |
2019 Q3
23 quarters
|
|
446
SPX Corp
SPXC
$8.39B
| $18.3M | 0.03% |
109,357
+275
| +0.3% | +$40.3K |
2015 Q4
38 quarters
|
|
447
Hewlett Packard
HPE
$85.1B
| $18.3M | 0.03% |
894,797
-352,505
| -28% | -$5.91M |
2020 Q4
18 quarters
|
|
448
Zenas BioPharma
ZBIO
$1.61B
| $18M | 0.03% |
1,861,838
+703,838
| +61% | +$6.85M |
2024 Q3
3 quarters
|
|
449
Knife River
KNF
$2.73B
| $17.9M | 0.03% |
219,795
-89,365
| -29% | -$8.14M |
2023 Q2
8 quarters
|
|
450
Broadridge
BR
$19B
| $17.8M | 0.03% |
73,377
+29,980
| +69% | +$7.12M |
2023 Q2
8 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.